CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer combo aims to erase hidden leukemia cells
Disease control TerminatedThis study tested whether adding pirtobrutinib to venetoclax could clear remaining cancer cells in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who still had detectable disease after venetoclax alone. Only 3 people enrolled before the study w…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:20 UTC
-
Blood cancer transplant study tests safer drug combo to prevent deadly complication
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to find which of two drug combinations (cyclosporine and sirolimus with either MMF or post-transplant cyclophosphamide) better prevents a serious side effect call…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New hope for CLL patients: experimental drug shows promise in early trial
Disease control TerminatedThis study tested an experimental drug called umbralisib in 12 people with chronic lymphocytic leukemia (CLL) who had not received treatment before. The goal was to see if the drug could shrink or control the cancer. Because the study was stopped early, results are limited, but s…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Promising combo for High-Risk CLL falls short as trial ends early
Disease control TerminatedThis study tested a two-drug combination—pembrolizumab and ibrutinib—in people with high-risk chronic lymphocytic leukemia (CLL) who had not yet received treatment. The goal was to see if the drugs could improve the body's immune function and shrink or control the cancer. Only 5 …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Promising CLL combo trial halted early: what it means for patients
Disease control TerminatedThis study tested a two-drug combination (ibrutinib followed by ibrutinib plus venetoclax) in 30 adults with chronic lymphocytic leukemia (CLL) that had returned or stopped responding to prior treatment. The goal was to see if the drugs could clear the disease from the blood and …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
Cord blood transplant shows promise for tough blood cancers
Disease control TerminatedThis study looked at using umbilical cord blood transplants after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. It included 200 people and aimed to see how many survived one year after the transplant. The approach is intense and mean…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 03:58 UTC
-
Cancer combo trial halted: new hope for tough blood cancers?
Disease control TerminatedThis early-phase study tested whether combining two drugs, tafasitamab and parsaclisib, is safe and effective for adults with certain blood cancers (non-Hodgkin lymphoma or chronic lymphocytic leukemia) that had come back or stopped responding to prior treatments. The study enrol…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
Experimental blood cancer drug trial halted early – what happened?
Disease control TerminatedThis early-stage study tested a new drug called JBH492 in 25 people with chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL) whose cancer had returned or stopped responding to prior treatments. The main goal was to check the drug's safety and find the right dose. T…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:54 UTC